0001179110-18-001889.txt : 20180209 0001179110-18-001889.hdr.sgml : 20180209 20180209163030 ACCESSION NUMBER: 0001179110-18-001889 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180207 FILED AS OF DATE: 20180209 DATE AS OF CHANGE: 20180209 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Reumuth Mary CENTRAL INDEX KEY: 0001710969 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38150 FILM NUMBER: 18592195 MAIL ADDRESS: STREET 1: 100 BEAVER STREET STREET 2: SUITE 201 CITY: WALTHAM STATE: MA ZIP: 02453 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kala Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001479419 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 270604595 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 BEAVER STREET STREET 2: SUITE 201 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 781-996-5252 MAIL ADDRESS: STREET 1: 100 BEAVER STREET STREET 2: SUITE 201 CITY: WALTHAM STATE: MA ZIP: 02453 4 1 edgar.xml FORM 4 - X0306 4 2018-02-07 0 0001479419 Kala Pharmaceuticals, Inc. KALA 0001710969 Reumuth Mary C/O KALA PHARMACEUTICALS, INC. 100 BEAVER STREET, SUITE 201 WALTHAM MA 02453 0 1 0 0 Chief Financial Officer Stock Option (right to buy) 12.86 2018-02-07 4 A 0 70000 0 A 2028-02-06 Common Stock 70000 70000 D This option was granted on February 7, 2018 and vests with respect to 1/48th of the shares underlying the option at the end of each successive one-month period thereafter. /s/ Mary Reumuth 2018-02-09